Vincent Miles

Vincent Miles is an Executive Director at Abingworth LLP, where he identifies new investments and supports portfolio companies. With over 40 years of experience in the biotechnology industry, he previously served as Senior Vice President of Business Development at Alnylam Pharmaceuticals and held multiple Vice President roles at Millennium Pharmaceuticals. Earlier in his career, Miles worked at the Dana-Farber Cancer Institute and earned a doctorate in Biochemical Embryology from University College London. He currently holds board director positions at several biotechnology firms, including Personalis and IFM Therapeutics, while acting as a board observer for Nido Biosciences and Atsena Therapeutics. Prior to these roles, he served on the boards of Chiasma, Dicerna Pharmaceuticals, and Magellan Diagnostics. Miles leverages his extensive background in research and development, strategic planning, and corporate communications to guide early-stage biotechnology investments.